Free Trial

57,532 Shares in Bowhead Specialty Holdings Inc. (NYSE:BOW) Bought by The Manufacturers Life Insurance Company

Bowhead Specialty logo with Finance background

The Manufacturers Life Insurance Company purchased a new position in shares of Bowhead Specialty Holdings Inc. (NYSE:BOW - Free Report) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 57,532 shares of the company's stock, valued at approximately $1,458,000. The Manufacturers Life Insurance Company owned approximately 0.18% of Bowhead Specialty at the end of the most recent quarter.

A number of other large investors have also recently added to or reduced their stakes in the company. American Century Companies Inc. bought a new position in shares of Bowhead Specialty during the 2nd quarter worth approximately $23,148,000. Victory Capital Management Inc. bought a new position in Bowhead Specialty during the second quarter worth $15,973,000. Emerald Advisers LLC bought a new position in Bowhead Specialty during the second quarter worth $5,954,000. Emerald Mutual Fund Advisers Trust acquired a new position in shares of Bowhead Specialty in the second quarter valued at $4,901,000. Finally, Peregrine Capital Management LLC bought a new position in shares of Bowhead Specialty in the second quarter valued at about $3,073,000.

Analyst Upgrades and Downgrades

A number of research analysts recently commented on the stock. Morgan Stanley started coverage on shares of Bowhead Specialty in a research note on Monday, June 17th. They issued an "equal weight" rating and a $26.00 price target on the stock. Royal Bank of Canada reiterated an "outperform" rating and set a $32.00 target price on shares of Bowhead Specialty in a research note on Wednesday, August 7th. Keefe, Bruyette & Woods began coverage on Bowhead Specialty in a research note on Monday, June 17th. They issued a "market perform" rating and a $30.00 price target for the company. JPMorgan Chase & Co. started coverage on Bowhead Specialty in a research report on Monday, June 17th. They set a "neutral" rating and a $27.00 price objective on the stock. Finally, JMP Securities initiated coverage on shares of Bowhead Specialty in a research report on Monday, June 17th. They issued an "outperform" rating and a $31.00 target price for the company. Three research analysts have rated the stock with a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of "Hold" and an average price target of $29.20.

Check Out Our Latest Report on Bowhead Specialty

Bowhead Specialty Price Performance

NYSE:BOW traded up $0.82 on Friday, hitting $29.26. The company had a trading volume of 78,612 shares, compared to its average volume of 158,638. Bowhead Specialty Holdings Inc. has a 52 week low of $22.14 and a 52 week high of $32.55. The company's 50 day moving average price is $28.83.

Bowhead Specialty (NYSE:BOW - Get Free Report) last announced its quarterly earnings results on Tuesday, August 6th. The company reported $0.28 EPS for the quarter, beating analysts' consensus estimates of $0.27 by $0.01. The firm had revenue of $98.90 million during the quarter, compared to the consensus estimate of $94.28 million. The company's revenue for the quarter was up 51.0% on a year-over-year basis. As a group, analysts expect that Bowhead Specialty Holdings Inc. will post 1.3 EPS for the current year.

About Bowhead Specialty

(Free Report)

Bowhead Specialty Holdings Inc provides specialty property and casualty insurance products in the United States. It underwrites casualty insurance solutions for risks in the construction, distribution, heavy manufacturing, real estate, and hospitality segments; professional liability insurance solutions for financial institutions, private and public directors and officers liability insurance, errors and omissions liability insurance, and cyber segments; and healthcare solutions for hospitals, senior care providers, managed care organizations, miscellaneous medical facilities, and healthcare management liability segments.

Further Reading

Institutional Ownership by Quarter for Bowhead Specialty (NYSE:BOW)

Should you invest $1,000 in Bowhead Specialty right now?

Before you consider Bowhead Specialty, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bowhead Specialty wasn't on the list.

While Bowhead Specialty currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Opportunities Arise as Stock Market Rotates from Big Tech

Opportunities Arise as Stock Market Rotates from Big Tech

Discover how the great stock rotation is shaking up the market and what it means for your investments, including the companies poised for growth.

Recent Videos

Central Garden & Pet: Niche Focus, Big Growth Potential
Evolv Technologies Stock Up 59%: AI Security & 12-Month Forecast
Housing Prices Soar: These 3 Home Stocks May Benefit

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines